These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 32586735

  • 1. The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease.
    Kim DW, Hwang SY, Nam YJ, Kim D, Shin SJ, Yoon HE.
    Nutr Metab Cardiovasc Dis; 2020 Aug 28; 30(9):1476-1483. PubMed ID: 32586735
    [Abstract] [Full Text] [Related]

  • 2. The combined clinical impact of red blood cell distribution width and vascular calcification on cardiovascular events and mortality in patients with endstage kidney disease.
    Kim DW, Lee M, Lee KJ, Lee YH, Kim D, Shin SJ, Yoon HE.
    Kidney Res Clin Pract; 2022 May 28; 41(3):351-362. PubMed ID: 35286792
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Obi Y, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP.
    Nephrol Dial Transplant; 2018 Feb 01; 33(2):264-273. PubMed ID: 28064159
    [Abstract] [Full Text] [Related]

  • 4. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.
    Kovesdy CP, Ureche V, Lu JL, Kalantar-Zadeh K.
    Nephrol Dial Transplant; 2010 Sep 01; 25(9):3003-11. PubMed ID: 20299338
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biomarkers of vascular calcification and mortality in patients with ESRD.
    Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS.
    Clin J Am Soc Nephrol; 2014 Apr 01; 9(4):745-55. PubMed ID: 24458076
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
    El Baz TZ, Khamis OA, Ahmed Gheith OA, Abd Ellateif SS, Abdallah AM, Abd El Aal HC.
    Saudi J Kidney Dis Transpl; 2017 Apr 01; 28(1):51-60. PubMed ID: 28098103
    [Abstract] [Full Text] [Related]

  • 9. The Combined Prognostic Significance of Alkaline Phosphatase and Intracranial Arterial Calcifications in Hemodialysis Patients.
    Erez D, Fanadka F, Benchetrit S, Cohen-Hagai K.
    Am J Nephrol; 2021 Apr 01; 52(9):763-770. PubMed ID: 34569494
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
    Tatami Y, Yasuda Y, Suzuki S, Ishii H, Sawai A, Shibata Y, Ota T, Shibata K, Niwa M, Morimoto R, Hayashi M, Kato S, Maruyama S, Murohara T.
    Atherosclerosis; 2015 Dec 01; 243(2):349-55. PubMed ID: 26519631
    [Abstract] [Full Text] [Related]

  • 12. Serum alkaline phosphatase levels correlate with long-term mortality solely in peritoneal dialysis patients with residual renal function.
    Zhan X, Yang Y, Chen Y, Wei X, Xiao J, Zhang L, Yan C, Qiu P, Liu S, Hu Q, Chen Q, Wang Y.
    Ren Fail; 2019 Nov 01; 41(1):718-725. PubMed ID: 31409217
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients.
    Panh L, Ruidavets JB, Rousseau H, Petermann A, Bongard V, Bérard E, Taraszkiewicz D, Lairez O, Galinier M, Carrié D, Ferrières J.
    Atherosclerosis; 2017 May 01; 260():81-86. PubMed ID: 28371683
    [Abstract] [Full Text] [Related]

  • 15. Abdominal aortic calcification is associated with diastolic dysfunction, mortality, and nonfatal cardiovascular events in maintenance hemodialysis patients.
    Yoon HE, Chung S, Whang HC, Shin YR, Hwang HS, Chung HW, Park CW, Yang CW, Kim YS, Shin SJ.
    J Korean Med Sci; 2012 Aug 01; 27(8):870-5. PubMed ID: 22876052
    [Abstract] [Full Text] [Related]

  • 16. Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study.
    Hong D, Wu S, Pu L, Wang F, Wang J, Wang Z, Gao H, Zhang Y, Deng F, Li G, He Q, Wang L.
    BMC Nephrol; 2013 Jun 05; 14():120. PubMed ID: 23738982
    [Abstract] [Full Text] [Related]

  • 17. Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients.
    Ohya M, Otani H, Kimura K, Saika Y, Fujii R, Yukawa S, Shigematsu T.
    Clin Exp Nephrol; 2011 Dec 05; 15(6):877-83. PubMed ID: 21850576
    [Abstract] [Full Text] [Related]

  • 18. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL, Molina P, Cerverón MJ, Vila R, Bover J, Nieto J, Barril G, Martínez-Castelao A, Fernández E, Escudero V, Piñera C, Adragao T, Navarro-Gonzalez JF, Molinero LM, Castro-Alonso C, Pallardó LM, Jamal SA.
    Clin J Am Soc Nephrol; 2015 Apr 07; 10(4):654-66. PubMed ID: 25770175
    [Abstract] [Full Text] [Related]

  • 19. Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis.
    Fan Y, Jin X, Jiang M, Fang N.
    Sci Rep; 2017 Oct 16; 7(1):13224. PubMed ID: 29038525
    [Abstract] [Full Text] [Related]

  • 20. Association of diabetes with cardiovascular calcification and all-cause mortality in end-stage renal disease in the early stages of hemodialysis: a retrospective cohort study.
    Li Q, Li P, Xu Z, Lu Z, Yang C, Ning J.
    Cardiovasc Diabetol; 2024 Jul 18; 23(1):259. PubMed ID: 39026232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.